286 related articles for article (PubMed ID: 20672580)
1. [Benefits and risks of postmenopausal hormone replacement therapy. Symptoms improved but not a better outcome?].
MMW Fortschr Med; 2010 Jun; 152(24):18. PubMed ID: 20672580
[No Abstract] [Full Text] [Related]
2. Health risks after cessation of postmenopausal hormone therapy.
Pines A; Sturdee D; Birkhäuser M;
Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
[No Abstract] [Full Text] [Related]
3. Justification for the use of HRT in the long-term prevention of osteoporosis.
Stevenson JC
Maturitas; 2005 Jun; 51(2):113-26. PubMed ID: 15917151
[TBL] [Abstract][Full Text] [Related]
4. Rethinking postmenopausal hormone therapy.
Solomon CG; Dluhy RG
N Engl J Med; 2003 Feb; 348(7):579-80. PubMed ID: 12584364
[No Abstract] [Full Text] [Related]
5. Decision factors influencing hormone replacement therapy.
Rozenberg S; Kroll M; Vandromme J
Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():92-7; discussion 97-8. PubMed ID: 8624351
[No Abstract] [Full Text] [Related]
6. Hormone replacement therapy.
Reid IR
N Z Med J; 1994 Apr; 107(975):138. PubMed ID: 8145969
[No Abstract] [Full Text] [Related]
7. [Hormone replacement therapy following breast carcinoma].
Klijn JG; Bontenbal M
Ned Tijdschr Geneeskd; 1998 Jan; 142(3):113-7. PubMed ID: 9557007
[TBL] [Abstract][Full Text] [Related]
8. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
Rollins G
Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
[No Abstract] [Full Text] [Related]
9. [Hormone replacement therapy: curse or blessing?].
Schmidt M; Fink D; Lang U; Kimmig R
Gynakol Geburtshilfliche Rundsch; 2006; 46(4):165. PubMed ID: 17068400
[TBL] [Abstract][Full Text] [Related]
10. Is there a case for targeting hormone replacement therapy for osteoporosis at the menopause?
Stevenson JC
Osteoporos Int; 1998; 8 Suppl 1():S47-50. PubMed ID: 9682798
[No Abstract] [Full Text] [Related]
11. Are oestrogen deficiency and hormone replacement a distraction to the field of osteoporosis?
Kanis JA
Osteoporos Int; 1998; 8 Suppl 1():S51-6. PubMed ID: 9682799
[No Abstract] [Full Text] [Related]
12. [Various practical schemes of substitution hormone therapy].
Gaspard U
Rev Med Liege; 1994 Apr; 49(4):182-9. PubMed ID: 8209120
[No Abstract] [Full Text] [Related]
13. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
Magnusson C; Weiderpass E
Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
[TBL] [Abstract][Full Text] [Related]
14. Menopausal hormone replacement: not necessarily routine.
Guinan ME
J Med Assoc Ga; 1994 Apr; 83(4):205-8. PubMed ID: 8006547
[No Abstract] [Full Text] [Related]
15. [Benefits and risks in hormone substitute therapy in postmenopause].
Baljić T
Srp Arh Celok Lek; 1996; 124(5-6):143-6. PubMed ID: 9102835
[TBL] [Abstract][Full Text] [Related]
16. Postmenopausal hormone therapy: cardiovascular risks.
Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
[TBL] [Abstract][Full Text] [Related]
17. [Current trends in hormone therapy during menopause and postmenopause].
Suhonen S
Duodecim; 1994; 110(10):1011-8. PubMed ID: 7588094
[No Abstract] [Full Text] [Related]
18. A personal initiative for women's health: to challenge the Women's Health Initiative.
Genazzani AR; Gambacciani M
Gynecol Endocrinol; 2002 Aug; 16(4):255-7. PubMed ID: 12396552
[No Abstract] [Full Text] [Related]
19. Postmenopausal hormone therapy: from monkey glands to transdermal patches.
Davis SR; Dinatale I; Rivera-Woll L; Davison S
J Endocrinol; 2005 May; 185(2):207-22. PubMed ID: 15845914
[TBL] [Abstract][Full Text] [Related]
20. [Risks and benefits of postmenopausal hormone replacement therapy].
Szántó F
Orv Hetil; 1998 Nov; 139(44):2639-42. PubMed ID: 9842237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
